Experiment 66792

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationLI,AL: SHI,YD: LANDSMANN,B: SCHANOWSKI-BOIVIER,P: DIKTA,G: BAUER,U: ARTMANN,GM:. (1998). HEMORHEOLOGY AND WALKING OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASES PATIENTS DURING TREATMENT WITH GINKGO BILOBA EXTRACT.. 19(5)
Amount utilized
Compound isolated
DiseaseTO STUDY THE EFFECTS OF GINKGO BILOBA EXTRACT 761 FROM THE POINTS OF VIEW OF HEMORRHEOLOGY FOR PATIENTS OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD). THE TREATMENT WITH GB3 (240 MG.D-1) AND PAIN-FREE WALKING DISTANCE (PFWD) WERE CARRIED OUT 24 PAOD PATIENTS (12 NONDIABETIC, ND AND 12 DIABETIC, D) OVER 48 WK. THE PARAMETERS ERYTHROCYTES STIFFNESS (ES) AND RELAXATION TIME (RT), THE BLOOD PLASMA VISCOSITY (NETA), THE PLASMA FIBRINOGEN CONCENTRATION (CF) AND THE BLOOD SEDIMENTATION RATE (BSR), THE PFWD, AND MAXIMAL WALKING DISTANCE (MWD) WERE DETERMINED. THROUGHOUT 11 WK OF TREATMENT ES, RT, NETA, AND CF DECREASED GRADUALLY AND PFWD IMPROVED. BETWEEN 16 AND 48 WK, ES, AND RT WERE NO LONGER SIGNIFICANTLY DIFFERENT FROM THE CONTROLS, WHEREAS NETA AND CF DECREASED GRADUALLY BUT REMAINED HIGHER THAN NORMAL, BSR DECREASED, AND THE PFWD IMPROVED BY A FACTOR OF 3.8 TIMES (D) AND 3.3 TIMES (ND).
Dose amount240.0 MG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractACETONE EXT
GenderGIVEN TO BOTH SEXES